Maƙala

Methylene blue da ikirarin da suka shafi herpesvirus: kurajen leɓɓa, EBV, da kashe ƙarfin ƙwayoyin cuta

Methylene blue da ikirarin da suka shafi herpesvirus: kurajen leɓɓa, EBV, da kashe ƙarfin ƙwayoyin cuta

Kalma ɗaya tana ɗauke da ma'anoni biyu a wannan muhawara, kuma suna buƙatar sunaye daban-daban. Ma'ana ta farko ita ce kashe ƙarfin virion: rini, oxygen, da haske suna haɗuwa da ƙwayar cuta a cikin ruwa, su lalata ta har ta kasa yin kwafi. Ma'ana ta biyu ita ce magance kamuwa da cuta a jikin mutum: ƙarancin kurajen herpes na leɓɓa, saurin warkewa, ƙarancin fitar ƙwayoyin cuta daga jiki, ko raguwar yawan ƙwayoyin cutar Epstein-Barr. An nuna na farko sau da yawa ga ƙwayar cutar herpes simplex a dakin gwaje-gwaje. Ba a nuna na biyu ba ga methylene blue da ake sha a kan herpes simplex ko ƙwayar cutar Epstein-Barr. Da zarar an fayyace wannan bambanci, rarrabe wallafe-wallafen bincike ya zama mai sauƙi.

Akwai wani ruɗani na biyu tare da wannan. HSV da EBV suna cikin babban iyali ɗaya na ƙwayoyin cuta, amma suna jawo cututtuka daban-daban a sassan jiki daban-daban. Kurjin herpes na leɓɓa rauni ne a saman fata inda ƙwayar cuta ke yin kwafi mai lalata ƙwayoyin jiki a wurin: ana iya shafa rini a kansa kuma a haska wannan wurin. EBV yana ci gaba da zama a ɓoye a wuraren ajiyarsa cikin ƙwayoyin B da suka bazu a jini da nama na tsarin lymph, inda rinin da ake shafawa ko jan fitila ba za su iya kaiwa ga duk wuraren ajiyar ba. Sakamako daga wani yanayi ba ya zama hujja ga ɗayan. Masu karatu da suke son sanin hanyar gama-gari ta wannan rarrabewa za su same ta a jagorar karanta binciken methylene blue.

Kashe ƙarfin ƙwayoyin cuta da haske a dakin gwaje-gwaje: HSV a wajen ƙwayoyin jiki, ana buƙatar haske

Gwajin kai tsaye mafi tsufa ya yi amfani da sabbin samfuran ƙwayoyin cuta da aka ware daga marasa lafiya maimakon nau'i ɗaya na dakin gwaje-gwaje. A binciken 1975 na kashe ƙarfin herpesvirus hominis ta hanyar photodynamic, an haɗa samfura 37 da aka ware daga raunukan al'aura da baki da methylene blue mai 10 micromolar, aka bar su awa ɗaya a duhu, sannan aka raba su zuwa kashi na duhu da kashi na haske, inda aka haska kashin haske na minti biyar da bututun fitilar fluorescent guda biyu masu 15 watt a nisan 15 cm. Daga cikin samfura 37, 27 sun rasa ikon kamuwa da cuta da za a iya ganowa a haske kaɗai, kuma 4 sun ragu fiye da ninki 100. Samfuran kwatanci da aka ajiye a duhu sun riƙe ikon kamuwa da cuta: ba tare da haske ba, wannan maida hankali na rini bai kawar da ikon kamuwa da cuta daga samfurin ba.

Wani bincike na baya ya nuna yadda tasirin rini da haske kawai zai iya zama ƙanƙanta a wasu yanayi. A gwaje-gwajen 1979 na methylene blue, haske, da lantarki a kan HSV-1 da HSV-2, rini mai 10 micromolar tare da hasken fitilar incandescent na daƙiƙa 180 ya rage HSV-1 mai iya kamuwa da cuta da kusan 60 percent, wato kusan 0.4 log. Sai ƙara ƙaramin gudun lantarki na kai tsaye ne kawai ya sa wannan tsarin ya wuce raguwar 99.99 percent. Haske kaɗai, gudun lantarki kaɗai, da haske tare da gudun lantarki ba tare da rini ba sun yi tasiri kaɗan. Babban tasirin ya buƙaci na'urar lantarki, don haka bai kamata a kawo wannan takarda a matsayin hujjar cewa rini da fitila na yau da kullum suna samar da kashe ƙarfin ƙwayoyin cuta na 4 log akai-akai ba.

Daga nan, binciken yadda wannan ke aiki ya tambayi abin da ƙwayoyin cutar da aka yi wa wannan aikin har yanzu za su iya yi. Wani binciken 1980 a Journal of Clinical Investigation kan hanyoyin aikin photodynamic a HSV ya gano yankewa a zare ɗaya na DNA na ƙwayar cuta ba tare da yawan yankewar zaren biyu ba: virion da aka yi wa aikin har yanzu suna manne wa ƙwayoyin jiki kuma suna shiga cikinsu, amma balagarsu ta tsaya. Wani binciken 1997 kan zagayen kamuwa da cuta bayan methylene blue da haske ya tabbatar da wannan ta amfani da rini mai 1 micromolar da jan haske: babu babbar lalacewar murfin ƙwayar cuta, shiga ƙwayoyin jiki da sakin DNA sun kasance yadda suke, amma an hana yin kwafi tare da lalacewar DNA da ta dogara da haskawa. Wani kwatancen 1995 na singlet oxygen ya nuna cewa singlet oxygen yana taka rawa, tare da yiwuwar ƙarin halayen sinadarai na radical. Bayani kan yadda methylene blue ke shan haske kuma yake samar da oxygen mai saurin yin halayen sinadarai ya bayyana dalilin da ya sa rini, oxygen, da photons dole su haɗu a wurin da ake nufi.

Hujjar ƙididdiga mafi bayyana ta fito ne daga aikin da ya shafi kayan jini, wanda kuma shi ne gargaɗi mafi bayyana game da ɗora wa sakamako abin da bai nuna ba. A wani binciken 2013 na rage ƙwayoyin da ke jawo cuta a plasma ta amfani da jajayen LEDs masu 627 nm, HSV da aka ƙara cikin plasma ya ragu da kusan 5.2 log a 1 micromolar da 6.0 log a 10 micromolar bayan minti 60. Wannan cire gurɓatawa ne daga ruwan da aka haska, ba magance zaman ɓoye a ƙwayoyin jijiyoyi ba, kuma ba ya yin hasashen abin da ruwan da aka sha zai yi a cikin jikin da ba shi da haske.

Maganin raunuka a wurinsu: bincike ƙanƙane, tsofaffi, kuma sakamakonsu ya bambanta

Rahotannin magani a wurin rauni suna shafa rini a raunin sannan a haska shi, wanda aƙalla yake kiyaye tsarin haɗuwar abubuwan da aka yi amfani da shi a dakin gwaje-gwaje. Mafi tsufansu rahoton wani mutum ne mai eczema herpeticum, wato kamuwar HSV mai yaɗuwa a kan eczema da ake da ita. Rahoton 1975 na eczema herpeticum kan methylene blue da haske ya bayyana saurin samun sauƙi bayan shafa rini da haske a wurin, tare da rini mai 10 micromolar da ke kashe ƙarfin ƙwayoyin cuta a haske amma ba a duhu ba. Sharhin ya fayyace amfani da ruwan magani mai 0.1 percent a rabin wurin domin kwatanta sassan jikin mara lafiya ɗaya. A matsayin shaida kan kurajen herpes na leɓɓa, lura ne da mutum ɗaya daga wancan zamani, tare da rashin ingantaccen auna adadin hasken da aka yi amfani da shi.

Babban jerin rahotannin tarihi ya shafi raunukan al'aura. A jerin 1975 na marasa lafiya 56 masu herpes na al'aura, 36 sun karɓi methylene blue, amma 35 na farko kawai aka raba ba tare da son zuciya ba tsakanin rini iri uku, don haka rukunin bai zama gwaji mai tsari bayyananne ba. An ruwaito samun sauƙi cikin kusan awa 48 a kusan 70 percent na masu cutar da ke maimaituwa da aka yi wa magani, amma yawan dawowar cutar bai ragu sosai ba. Ba a sarrafa haskawa da fitilar fluorescent ko hasken rana a gida ba. Samun sauƙi a lokacin da cutar ta bayyana ba tare da rage maimaituwarta ba ya dace da aikin da ke shafar raunin da yake nan amma ba wurin ajiyar ƙwayar cuta a ɓoye ba. Ana buƙatar irin wannan taka tsantsan game da ka'idojin maganin photodynamic da ke amfani da methylene blue.

Gwaje-gwajen zamani kan kurajen herpes na leɓɓa ƙanana ne kuma ba su cimma sakamako iri ɗaya ba. Wani jerin rahotanni na 2009 na marasa lafiya huɗu masu herpes labialis ya yi amfani da rini mai 0.01 percent tare da laser mai 660 nm a 120 J per square cm kuma ya ruwaito saurin warkewa, amma babu rukunin kwatanci kuma an yi photobiomodulation daga baya, kamar yadda aka bayyana a jerin rahotannin 2009 na photodynamic ga herpes labialis. Raba marasa lafiya 75 ba tare da son zuciya ba zuwa photodynamics, acyclovir na shafawa, ko duka biyun bai gano bambanci a lokacin warkewa ko zafi ba, bisa ga gwajin 2021 na maganin photodynamic da acyclovir. Wani gwajin marasa lafiya 24 da aka raba ba tare da son zuciya ba, tare da qPCR na HSV-1, bai gano bambanci a gushewar raunuka ko maimaituwar cutar cikin shekara ɗaya ba, kamar yadda aka bayyana a gwajin 2025 da aka raba ba tare da son zuciya ba na maganin photodynamic mai kashe ƙananan halittu ga herpes simplex. Wani gwajin 2025 na marasa lafiya 60 da ya haɗa photodynamics na rini, photobiomodulation, da fitar da ruwa daga kumfa ya ruwaito saurin sauƙin zafi wanda ba za a iya danganta shi ga rinin ba, bisa ga rahoton 2025 na haɗa photodynamic da photobiomodulation.

Rahotannin illa a nan ba su wadatar ba. Takardun 1975 ba su da tsarin gano illoli na zamani. Ƙananan binciken da suka biyo baya sun ruwaito kaɗan ko babu illolin da suka bayyana nan da nan, amma barin launin shuɗi yana cikin halayen rinin, kuma har yanzu akwai yiwuwar ƙaiƙayi ko kumburi a wurin saboda tasirin guba da haske ke haifarwa. Shafawa da fitila sun bambanta da shan rinin, shi ya sa bayanan aminci na methylene blue suke la'akari da kowace hanyar amfani daban.

EBV: babu shaida kai tsaye ta methylene blue

Game da EBV, binciken bai gano shaida ba. Babu gwajin dakin gwaje-gwaje da masana suka tantance ko gwajin da ke da rukunin kwatanci da aka samu don wannan bita wanda ya nuna methylene blue, tare da haske ko ba tare da shi ba, yana rage ikon EBV na kamuwa da cuta, hana sake kunnawarsa, ko rage yawan ƙwayar cutar a mutane. Aikin da ya shafi ƙwayoyin kansar nasopharynx masu EBV yana amfani da wasu sinadarai masu sa ƙwayoyin su ji tasirin haske, kuma yana auna ikon ƙwayoyin ƙari na rayuwa, ba kawar da ƙwayar cuta da methylene blue ba. Bitocin bincike suna lissafa EBV cikin ƙwayoyin cuta da ke buƙatar gwaje-gwaje na gaba, ba cikin amfanin da aka tabbatar ba.

Ilimin halittu ya bayyana dalilin da ya sa ba za a ɗauki sakamakon HSV a bututun gwaji a yi amfani da shi ga EBV ba. Maganin kurajen herpes na leɓɓa yana sanya dukan abubuwa ukun da ake buƙata, wato rini, oxygen, da photons, a saman wuri ɗaya da ake iya kaiwa gare shi. EBV da ke ɓoye yana zama galibi a ƙwayoyin B da suka bazu a jini da nama na tsarin lymph. Jan hasken da ake amfani da shi a wurin ba zai iya haska wannan ma'ajiyar da ta bazu ba, kuma rinin da aka sha ba ya samar da hasken da aka nufa ga waɗannan wurare. Kashe ƙwayar ƙari mai EBV da wani sinadari dabam mai sa ta ji tasirin haske kashe ƙwayar jiki ne, ba hujjar aikin yaƙi da ƙwayar cuta ba. Wannan giɓin yana da muhimmanci yayin karanta yadda ake auna yawan ƙwayoyin cuta da alamomin sake kunnawarsu a zahiri.

Magani ta baki da kuskuren ɗaukar lokacin rashin maimaituwa a matsayin hujja

Babu gwajin mutane da ke da rukunin kwatanci da aka samu don wannan bita wanda ya nuna methylene blue da ake ba wa jiki gaba ɗaya ko ake sha yana rage maimaituwar kurajen herpes na leɓɓa, rage lokacin warkewa, rage fitar ƙwayoyin cuta daga jiki, ko canza kowane ma'aunin sakamakon EBV kamar adadin kwafin DNA a jini ko yawu, ko takamaiman alamomin yin kwafi mai lalata ƙwayoyin jiki. Wallafe-wallafen herpes a mutane suna amfani da rini na shafawa tare da haske a wurin. Bayar da magani ga jiki gaba ɗaya ba tare da haskawa a wurin da aka nufa ba hanya ce daban, kuma tana buƙatar gwajinta: raba mahalarta ba tare da son zuciya ba, ɓoye sanin nau'in maganin da aka ba su, da rukunin kwatanci na placebo, tare da tabbatattun masu cutar da ke maimaituwa, lokacin lura kafin gwaji don tantance yawan maimaituwa na asali, gwaje-gwajen tabbatar da an samu magani da aka tsara tun farko, bin diddigi na wata shida zuwa goma sha biyu, ɗaukar samfura da auduga a jere tare da qPCR, rubuta abubuwan da ke tayar da cutar, da sa ido kan aminci. Ka'idoji na gama-gari kan bayar da methylene blue ta baki da shigarsa cikin jiki ba sa maye gurbin waɗannan ma'aunan sakamako.

A nan ne wani labari da ake yawan bayarwa yake gaza. Wani ya fara hanyoyin magani da yawa a lokaci ɗaya, ya ruwaito rashin kurajen herpes na leɓɓa na watanni, kuma ya danganta hakan ga ɗaya daga cikinsu. Fashewar HSV tana iya taruwa cikin lokaci ɗaya sannan ta ɓace na watanni ba tare da kawar da ƙwayar cutar daga ganglia na jijiyoyin ji ba. Abubuwan da ke tayar da cutar suna sauyawa, abin da mutum yake tsammani yana canza yadda yake bayar da rahoto, kuma kwatsam kaɗai yana iya haifar da waɗannan tazarori. Idan an yi sauye-sauye da yawa lokaci guda, babu kwatancin abin da zai faru ba tare da ɗaya daga cikinsu ba da zai danganta tazarar ga wannan abu ɗaya. Jerin rahotannin al'aura na 1975 ya nuna akasin haka: samun sauƙi a lokacin bayyanar cutar tare da rashin ingantuwar yawan dawowarta. Warkar da wannan fashewar cuta ba abu ɗaya ba ne da hana ta gaba.

Teburin shaidu bisa ƙwayar cuta da yanayin bincike

Ƙwayar cuta da yanayiHanyar da aka yi amfani da itaBabban sakamakoAbin da ba zai iya nunawa ba
Samfuran HSV da aka ware, ba tare da ƙwayoyin jiki ba, 1975, n=37Rini mai 10 micromolar, fitilar fluorescent 5 min27 sun rasa ƙarfin kamuwa da cuta gaba ɗaya a haske, 4 sun ragu fiye da ninki 100, samfuran kwatanci na duhu ba su canza baWarkewar marasa lafiya, kawar da zaman ɓoye, adadin magani ga mutane
Virion na HSV-1 da HSV-2, 1979Rini mai 10 micromolar, hasken incandescent 180 s, tare da gudun lantarki da ba tare da shi baRini da haske kaɗai sun rage kusan 60 percent; fiye da 99.99 percent sai da ƙarin gudun lantarki kawaiCewa rini da fitila na yau da kullum suna samar da kashe ƙarfin ƙwayoyin cuta mafi girma
Yadda ake shafar genome na HSV, 1980 da 1997Rini mai ƙaramin micromolar tare da haskeIkon shiga ya kasance, lalacewar zare ɗaya na DNA, an hana yin kwafi, lalacewa tare da tsawon lokacin haskawaKashe ƙwayoyin jiki da suka riga suka kamu kai tsaye
HSV a plasma na mutum, 2013Rini mai 1 da 10 micromolar, LEDs masu 627 nm, 60 minRaguwar kusan 5.2 da 6.0 logMagani ta baki ko tasiri kan zaman ɓoye a ƙwayoyin jijiyoyi
Eczema herpeticum, 1975, rahoton mutum ɗayaShafa 0.1 percent a rabin wurin tare da haskeAn ruwaito saurin ingantuwar alamomin cuta da ma'aunan ƙwayar cutaIngancin magani ga kurajen herpes na leɓɓa gaba ɗaya; ba a iya gano adadin hasken da aka yi amfani da shi ba
Herpes na al'aura, 1975, marasa lafiya 56Shafa 0.1 percent, hasken fluorescent ko hasken rana a gidaSamun sauƙi a lokacin bayyanar cuta a kusan 70 percent; dawowar cutar ba ta ragu sosai baHana maimaituwa
Herpes labialis, 2009, n=40.01 percent, 660 nm, 120 J per square cm, sannan photobiomodulationAn ruwaito saurin warkewaTabbatar da cewa rinin ne ya haifar da tasirin; ba a fassara maimaituwar cutar ba
Labialis mai maimaituwa, 2021, n=75Photodynamics na 0.005 percent idan aka kwatanta da acyclovir ko duka biyunBabu bambanci a lokacin warkewa ko zafiKashe ƙarfin virion don yaƙi da ƙwayar cuta
Herpes simplex na baki, 2025, n=24Photodynamics mai kashe ƙananan halittu idan aka kwatanta da acyclovir, tare da qPCRBabu bambanci a gushewar raunuka ko maimaituwa cikin shekara ɗayaAmfani ga jiki gaba ɗaya ko ga EBV
Labialis mai maimaituwa, 2025, n=60Haɗa photodynamics, photobiomodulation, da fitar da ruwaSaurin sauƙin zafi a rukunin da aka yi wa haɗaɗɗun hanyoyinTasirin methylene blue shi kaɗai
EBV, kowane yanayin da ya shafi mutaneKowace hanyar amfani da methylene blueBa a samu bincike kai tsaye ba; ba a nuna tasiri kan yawan ƙwayar cuta ko sake kunnawarta baƊaukar kashe ƙarfin HSV da haske a matsayin shaida ga EBV
Amfani ga jiki gaba ɗaya ko ta baki don HSV ko EBVRini ta baki ko ga jiki gaba ɗaya ba tare da hasken da aka nufa baBa a samu gwajin yaƙi da ƙwayar cuta mai rukunin kwatanci baAmfani ga alamomin cuta ko ma'aunan ƙwayar cuta

Yadda za a yi amfani da wannan shaida

Yi tambayoyi huɗu ga kowane binciken da aka kawo. Haske ne ko duhu, domin kashe ƙarfin ƙwayoyin cuta ta hanyar photodynamic ba ya yin hasashen kashe su a jiki gaba ɗaya. Virion masu zaman kansu ne, raunin da yake nan ne, ko wurin ajiyar ƙwayar cuta a ɓoye, domin abin da aka nufa da ya dace ne kawai zai amsa ikirarin. Ikon kamuwa da cuta ne, warkewa, maimaituwa, ko yawan ƙwayar cuta, domin lambar ikon kamuwa da cuta ba za ta iya amsa tambayar maimaituwa ba. HSV ne ko EBV, domin raunin da ake iya kaiwa gare shi da wuraren ajiyar ƙwayoyin B da suka bazu matsaloli ne daban-daban. Shaidun da ake da su suna goyon bayan bayani ɗaya mai iyaka: methylene blue yana iya kashe ƙarfin HSV sosai ta hanyar haske idan ƙwayar cutar da ke wajen ƙwayoyin jiki ta haɗu da rini, oxygen, da hasken da ya dace. Shaidar maganin raunuka masu maimaituwa da ke da muhimmanci a aikin kula da marasa lafiya tana da iyaka kuma sakamakonta ya bambanta, babu shaida ta rigakafin maimaituwa ta hanyar shan magani, kuma babu shaida kai tsaye ta tasirin yaƙi da EBV. Lokacin da ba a samu kurajen herpes na leɓɓa ba yayin amfani da tsarin magunguna da yawa ba ya canza ko ɗaya daga cikin waɗannan.